News Conference News AHA 2016 Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention Yael L. Maxwell November 29, 2016
News Conference News AHA 2016 En mitad de la Marea Creciente de ECVA, los Costes del Tratamiento Deberían hacer que los Legisladores Legislasen en Materia de Prevención Yael L. Maxwell November 29, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel Michael O'Riordan June 09, 2016
News Daily News No More Niacin, Fibrate Combinations With Statins: FDA Michael O'Riordan April 19, 2016
News Features PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data Michael O'Riordan January 25, 2016
News Daily News Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos August 13, 2015
News Daily News IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy Yael L. Maxwell June 05, 2015
News Conference News ESC 2012 ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations Caitlin E. Cox September 04, 2012
News Conference News ESC 2012 Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming Caitlin E. Cox August 26, 2012
News Daily News Statin Users Have Better Outcomes After PCI for Stable CAD L.A. McKeown July 08, 2011